FDANonrulemakingFDA-2025-N-0816
Who commented on this docket
Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments
1 organizations filed 1 public comment on Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments, at the Food and Drug Administration. The comment window closed 348d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 348d ago
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.